{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:39:38Z","timestamp":1790134778460,"version":"4.0.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Pharmacotherapy"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.amjopharm.2006.08.001","type":"journal-article","created":{"date-parts":[[2006,10,24]],"date-time":"2006-10-24T17:58:15Z","timestamp":1161712695000},"page":"201-209","source":"Crossref","is-referenced-by-count":27,"title":["Escitalopram for comorbid depression and anxiety in elderly patients: A 12-week, open-label, flexible-dose, pilot trial"],"prefix":"10.1016","volume":"4","author":[{"given":"Somaia","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerine","family":"Osatuke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kasckow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjopharm.2006.08.001_bib1","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0193-953X(03)00040-6","article-title":"Anxiety disorders in women","volume":"26","author":"Pigott","year":"2003","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0193-953X(05)70211-2","article-title":"Generalized anxiety disorder in the elderly","volume":"24","author":"Dada","year":"2001","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib3","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1176\/ajp.156.12.1915","article-title":"Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys","volume":"156","author":"Kessler","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1192\/S0007125000298371","article-title":"Comorbidity of DSM-III-R major depressive disorder in the general population: Results from the US National Comorbidity Survey","author":"Kessler","year":"1996","journal-title":"Br J Psychiatry Suppl"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00004850-200015060-00002","article-title":"Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey","volume":"15","author":"Wittchen","year":"2000","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib6","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1176\/ajp.153.10.1293","article-title":"Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders","volume":"153","author":"Brown","year":"1996","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00019442-199700520-00003","article-title":"Anxious depression in elderly patients. Response to antidepressant treatment","volume":"5","author":"Flint","year":"1997","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0165-0327(02)00177-5","article-title":"Good treatment outcomes in late-life depression with comorbid anxiety","volume":"77","author":"Lenze","year":"2003","journal-title":"J Affect Disord"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib9","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1176\/appi.ajp.162.4.718","article-title":"Remission in depressed geriatric primary care patients: A report from the PROSPECT study","volume":"162","author":"Alexopoulos","year":"2005","journal-title":"Am J Psycbiatry"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib10","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jama.291.9.1081","article-title":"Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: A randomized controlled trial","volume":"291","author":"Bruce","year":"2004","journal-title":"JAMA"},{"issue":"Suppl 3","key":"10.1016\/j.amjopharm.2006.08.001_bib11","doi-asserted-by":"crossref","first-page":"61S","DOI":"10.1097\/00004714-199006001-00012","article-title":"Anxiety and depression: Discrete diagnostic entities?","volume":"10","author":"Liebowitz","year":"1990","journal-title":"J Clin Psycbopbarrnacol"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/(SICI)1520-6394(1996)4:4<160::AID-DA2>3.0.CO;2-J","article-title":"Comorbid depression and anxiety spectrum disorders","volume":"4","author":"Gorman","year":"1996","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib13","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2165\/00002512-200320120-00002","article-title":"Diagnosis and management of panic disorder in older patients","volume":"20","author":"Flint","year":"2003","journal-title":"Drugs Aging"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/(SICI)1520-6394(1999)9:3<107::AID-DA2>3.0.CO;2-T","article-title":"International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: VI. Trends in recommendations for the pharmacotherapy of anxiety disorders, 1992\u20131997","volume":"9","author":"Uhlenhuth","year":"1999","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/(SICI)1520-6394(2000)11:3<93::AID-DA2>3.0.CO;2-7","article-title":"Social anxiety disorder under scrutiny","volume":"11","author":"Davidson","year":"2000","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib16","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4088\/JCP.v66n0510","article-title":"Why isn't bupropion the most frequently prescribed antidepressant?","volume":"66","author":"Zimmerman","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib17","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.4088\/JCP.v65n0903","article-title":"National trends in the outpatient treatment of anxiety disorders","volume":"65","author":"Olfson","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00002512-200522020-00002","article-title":"Generalised anxiety disorder in elderly patients: Epidemiology, diagnosis and treatment options","volume":"22","author":"Flint","year":"2005","journal-title":"Drugs Aging"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib19","first-page":"39","article-title":"Anxiety disorders in the elderly. Generations","volume":"17","author":"Gurian","year":"1993","journal-title":"J Am Soc Aging"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib20","series-title":"Clinical Geriatric Psycbopbarrnacology","year":"1998"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib21","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1192\/bjp.187.5.462","article-title":"Adherence to guidelines for treatment of depression in in-patients","volume":"187","author":"Schneider","year":"2005","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/1381612023396654","article-title":"Cognitive and sedative effects of benzodiazepine use","volume":"8","author":"Buffett-Jerrott","year":"2002","journal-title":"Curr Pharrn Des"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib23","first-page":"1015","article-title":"Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: A randomized trial","volume":"169","author":"Baillargeon","year":"2003","journal-title":"CMAJ"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib24","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2165\/00002512-200219100-00004","article-title":"Anxiety symptoms in elderly patients with depression: What is the best approach to treatment?","volume":"19","author":"Lenze","year":"2002","journal-title":"Drugs Aging"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00131746-200111000-00003","article-title":"Pharmacotherapy of depression in older patients: A summary of the expert consensus guidelines","volume":"7","author":"Alexopoulos","year":"2001","journal-title":"J Psychiatr Pract"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib26","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0006-3223(00)00957-4","article-title":"Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline","volume":"48","author":"Stahl","year":"2000","journal-title":"Biol Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.amjopharm.2006.08.001_bib27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1017\/S1092852900028595","article-title":"Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: Pooled analysis of placebo-controlled trials","volume":"7","author":"Gorman","year":"2002","journal-title":"CNS Spear"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jad.2004.11.011","article-title":"Treatment of generalized anxiety disorder with escitalopram: Pooled results from double-blind, placebo-controlled trials","volume":"87","author":"Goodman","year":"2005","journal-title":"J Affect Disord"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib29","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br J Med Psycbol"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib31","series-title":"International Conference on Harmonisation-World Health Organization. Guideline for Good Clinical Practice [EMEA Web site]","author":"European Agency for the Evaluation of Medicinal Products","year":"2002"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib32","series-title":"Recommendations Guiding Medical Doctors in Biomedical Research Involving Human Subjects [WMA Web site]","author":"World Medical Association Declaration of Helsinki","year":"1989"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib33","series-title":"Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00004714-198708000-00002","article-title":"The value of selfreport assessment in studies of anxiety disorders","volume":"7","author":"Glass","year":"1987","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib35","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), Clinician Version","author":"First","year":"1997"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib36","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item shortform health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib37","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1176\/appi.ajp.162.6.1179","article-title":"Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: A 12-year prospective study","volume":"162","author":"Bruce","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1176\/appi.ajgp.13.1.31","article-title":"Depression and generalized anxiety disorder: Cooccurrence and longitudinal patterns in elderly patients","volume":"13","author":"Schoevers","year":"2005","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib39","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/gps.688","article-title":"Just keep taking the tablets: Adherence to antidepressant treatment in older people in primary care","volume":"17","author":"Maidment","year":"2002","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib40","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1034\/j.1600-0560.2002.56.x","article-title":"The 2030 problem: Caring for aging baby boomers","volume":"37","author":"Knickman","year":"2002","journal-title":"Health Serv Res"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib41","series-title":"Comprebensiroe Textbook of Geriatric Psychiatry","first-page":"3","article-title":"Epidemiology of psychiatric disorders","author":"Gurland","year":"2004"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib42","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2165\/00023210-200519040-00004","article-title":"Social functioning: Should it become an endpoint in trials of antidepressants?","volume":"19","author":"Bech","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib43","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.286.23.2947","article-title":"Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: A randomized trial","volume":"286","author":"Kroenke","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0006-3223(01)01291-4","article-title":"Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination","volume":"51","author":"Hirschfeld","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib45","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00005650-199406000-00002","article-title":"Comparisons of the costs and quality of norms for the SF-36 health survey collected by mail versus telephone interview: Results from a national survey","volume":"32","author":"McHorney","year":"1994","journal-title":"Med Care"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib46","doi-asserted-by":"crossref","first-page":"668","DOI":"10.4088\/JCP.v60n1005","article-title":"Zolpidem for persistent insomnia in SSRI-treated depressed patients","volume":"60","author":"Asnis","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib47","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0011-393X(05)80159-6","article-title":"Comparison of the efficacy and tolerability of zolpidem 20 mg and triazolam 0.5 mg in anxious or depressed insomniac patients","volume":"53","author":"Pagot","year":"1993","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib48","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4088\/JCP.v63n0410","article-title":"Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients","volume":"63","author":"Burke","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00004850-200205000-00001","article-title":"Escitalopram 10 mg\/day is effective and well tolerated in a placebo-controlled study in depression in primary care","volume":"17","author":"Wade","year":"2002","journal-title":"Int Clin Psycbopbarmacol"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib50","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1034\/j.1600-0773.2001.d01-118.x","article-title":"Escitalopram (S-enantiomer of citalopram): Clinical efficacy and onset of action predicted from a rat model","volume":"88","author":"Montgomery","year":"2001","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib51","first-page":"1","article-title":"Prevention of relapse in generalized anxiety disorder by escitalopram treatment","author":"Allgulander","year":"2005","journal-title":"Int J Neuropsychopharmacolacol"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib52","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/da.10146","article-title":"Escitalopram in the treatment of generalized anxiety disorder: Double-blind, placebo controlled, flexible-dose study","volume":"19","author":"Davidson","year":"2004","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.amjopharm.2006.08.001_bib53","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/10401230590932335","article-title":"Escitalopram for the treatment of GAD: Efficacy across different subgroups and outcomes","volume":"17","author":"Stein","year":"2005","journal-title":"Ann Clin Psychiatry"}],"container-title":["The American Journal of Geriatric Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594606000444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594606000444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T13:45:53Z","timestamp":1683639953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1543594606000444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S1543594606000444"],"URL":"https:\/\/doi.org\/10.1016\/j.amjopharm.2006.08.001","relation":{},"ISSN":["1543-5946"],"issn-type":[{"value":"1543-5946","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}